Intravenous versus intrathecal dexmedetomidine as an additive to hyperbaric bupivacaine in spinal anesthesia for hip arthroplasty. A randomized controlled trial

Abdelrhman Alshawadfy; Mohamed A. Elsadany; Amira Mahfouz Elkeblawy; Ahmed A. El-Lilly

doi:10.1080/11101849.2022.2085974

Q3 2022

Intravenous versus intrathecal dexmedetomidine as an additive to hyperbaric bupivacaine in spinal anesthesia for hip arthroplasty. A randomized controlled trial

Abdelrhman Alshawadfy · Mohamed A. Elsadany · Amira Mahfouz Elkeblawy · Ahmed A. El-Lilly

10.1080/11101849.2022.2085974 389 Views 5 Citations

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Abdelrhman, A., Mohamed, A. E., Amira, M. E., Ahmed, A. E. (2022). Intravenous versus intrathecal dexmedetomidine as an additive to hyperbaric bupivacaine in spinal anesthesia for hip arthroplasty. A randomized controlled trial. Egyptian Journal of Anaesthesia. https://doi.org/10.1080/11101849.2022.2085974